I guess the wildcard is that while clinical trials might still be in the distance the beauty is as a platform technology a substantial deal could come out of the blue at any time. Who knows we might announce we are going to collaborate with Laura Soucek or any one of the apparently numerous interested pharma. I guess that has always been the dangling carrot with these guys though.would be nice to see it come to fruition although realistically i guess any deal would only be a discovery and access type deal at this stage so no huge upfronts?
I guess the wildcard is that while clinical trials might still...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |